for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-AIM ImmunoTech Says Co Entered Into Material Transfer & Research Agreement With The University Of Rochester

June 5 (Reuters) - AIM ImmunoTech Inc:

* AIM IMMUNOTECH SAYS ON JUNE 1, ENTERED INTO MATERIAL TRANSFER & RESEARCH AGREEMENT WITH THE UNIVERSITY OF ROCHESTER - SEC FILING

* AIM IMMUNOTECH - WILL BE PROVIDING UNIVERSITY WITH AMPLIGEN

* AIM IMMUNOTECH - UNIVERSITY PLANS TO CONDUCT SERIES OF IN VITRO EXPERIMENTS TO TEST DIRECT ANTIVIRAL ACTIVITY & MECHANISM OF ACTION OF AMPLIGEN ON SARS-COV-2 Source text: (bit.ly/3dGiP5S) Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up